Senior Scientist (Illumina Micro Array Technology) | GenomeWeb

Senior Scientist (Illumina Micro Array Technology)

Organization
Illumina
Job Location
Cambridgeshire
CB21 6GP
United Kingdom
Salary
Industry leading package
Benefits

Company equity, annual bonus scheme, 10% pension, 25 days annual leave, private healthcare and more!

Job Description

About the team:

Illumina’s reproductive and genomics solutions use next-generation sequencing (NGS) and advanced microarray technologies to produce fast, accurate genomic information in clinical research and diagnostics. Combining industry-leading technologies with innovative reproductive and genetic health applications, Illumina provides the highest detection capability for genetic abnormalities during all stages of reproductive health and beyond.  Across the reproductive continuum, Illumina technologies deliver valuable tools for researchers and healthcare professionals.

 

 

About the role:

This role lies at the heart of Illumina RGH’s microarray production and support function in the UK (Fulbourn, Cambridgeshire).  Working with Production, Quality Assurance, Product Development, Technical Support and Commercial, this person will be the go-to person for all high-level technical queries about microarray and associated technologies used on the site.  This is a highly variable role with the post holder expected to be involved with:

 

  • Leading a team responsible for the Quality Control of manufactured microarrays, and the production and QC of company consumable products
  • Development and performance management of direct reports and Planning and effective utilization of available resources
  • High level technical support and troubleshooting  (microarray data interpretation) for both internal and external stakeholders, process development and quality
  • Validation of new automation and instrumentation used in production

 

  • Transitioning new products into manufacturing

 

 

Key Outputs:

  • Manufacture and delivery of products, on time and in full, as specified and in accordance with requirements of the production plan
  • Maintenance of specified product performance quality standards
  • Satisfactory investigation and resolution of production issues to ensure delivery of planned requirements
  • Effective development, validation and implementation of process and product improvement activities
  • Development and refinement of product specifications

 

This is a fantastic opportunity to be at the heart of Illumina’s microarray business and to help leverage this technology into new and exciting clinical and diagnostic markets.  If you are passionate about array technology and it’s applications, then this is an ideal opportunity.

Requirements

Candidate requirements:

 

  • PhD in relevant life sciences subject area
  • Proven experience working with microarray technology (DNA or RNA) both from the design, trouble shooting and data analysis perspective
  • Strong communication skills – comfortable liaising with both internal and external stakeholders
  • Excellent analytical and problem solving skills
  • Proven data analysis and synthesis skills
  • Self-motivated and disciplined – must be able to work independently and deliver results in a fast paced and reactive environment
How to Apply

Interested parties should log into Illumina’s career pages and use the reference 2406BR:

 

http://www.illumina.com/company/careers.html

About Our Organization

About Illumina:

Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
 
lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.4 billion in 2013. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review.  As of August 2014, the company had a $24 billion market capitalization.

The GRE isn't a good predictor of graduate school performance or productivity, according to two PLOS One studies.

Bitesize Bio has some advice for scientists ready to leave their current lab behind.

A trio of editors from the Nature family of journals describes what make a peer review a good one.

Spots in genetic counseling training programs are competitive, Maclean's reports.